Articles by Disease (Head And Neck Cancers)

Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects

Journal: Current Pharmaceutical Design
Volume: 18
Page: 2702-2712
Author(s): Marco Petrillo, Maddalena Borriello, Gilda Fuoco, Francesco Legge, Vito Iannone and Gabriella Ferrandina

Targeting mTOR Pathways in Human Malignancies

Journal: Current Pharmaceutical Design
Volume: 18
Page: 2766-2777
Author(s): Angelica Fasolo and Cristiana Sessa

Novel Drugs Targeting Microtubules: the Role of Epothilones

Journal: Current Pharmaceutical Design
Volume: 18
Page: 2793-2803
Author(s): Gabriella Ferrandina, Marisa Mariani, Mirko Andreoli, Shohreh Shahabi, Giovanni Scambia and Cristiano Ferlini

Molecular Targets of Gemcitabine Action: Rationale for Development of Novel Drugs and Drug Combinations

Journal: Current Pharmaceutical Design
Volume: 18
Page: 2811-2829
Author(s): Maha Elnaggar, Elisa Giovannetti and Godefridus J. Peters

Chemoradiotherapy of Human Tumors: Novel Approaches from Nanomedicine

Journal: Current Pharmaceutical Design
Volume: 18
Page: 2830-2837
Author(s): Michael Edward Werner, Michael Bonner Foote and Andrew Zhuang Wang

Application of Monoclonal Antibodies as Cancer Therapy in Solid Tumors

Journal: Current Clinical Pharmacology
Volume: 7
Page: 137-145
Author(s): Rodrigo Dienstmann, Ben Markman and Josep Tabernero

Role of Cytokines in the Pathophysiology of Acute Graft-Versus-Host Disease (GVHD)– Are Serum/Plasma Cytokines Potential Biomarkers for Diagnosis of Acute GVHD Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)?

Journal: Current Stem Cell Research & Therapy
Volume: 7
Page: 229-239
Author(s): Tomomi Toubai, Junji Tanaka, Sophie Paczesny, Yusuke Shono, Pavan Reddy and Masahiro Imamura